Founding offer · lifetime membership for a single £24, exclusive to our first members · closes 20 June Claim your place →
Global Research Partnerships £24 Lifetime Log inCreate free account

Funded Projects › HORIZON

VIR-Quantify · Nanowire device for single virus delivery and sensing in vacuum

HORIZONStatus: SIGNED1 July 202431 December 2025EU funding €150,000Call ERC-2023-POC

Airborne viruses causing respiratory diseases represent a mayor global health threat, being viruses with RNA-genomes from animal reservoirs highly likely to cause further public health emergencies in the future. VIR-Quantify aims to provide proof of concept for a technology capable of highly sensitive, fast and untargeted airborne virus detection with infectivity assessment, providing a comparative advantage in the competitive landscape. VIR-Quantify builds upon an unprecedented application of NMS sensors to the field of airborne viral particles detection (methodology developed and patented by the PI in the framework of a previous ERC CoG). VIR-Quantify proposes the use of ionic liquids to preserve the virus structure, together nanowire sensors that allow mass and stiffness measurements for identification and infectivity studies of the pathogens. The innovative solution lies in two fronts: 1) an unprecedented capability to measure with high throughput (30 particles/minute) the stiffness of intact viruses to infer their infectivity potential, not at reach to other techniques, 2) the capability to count and characterize all the viral particles present in the liquid sample without loss of bioanalytes during the measurements.VIR-Quantify aims to exploit the novel technology for on-site identification and quantification of airbone viral particles and validate the innovation potential of such technological tool for commercialization by developing a market entry strategy built upon IPR consolidation and spin-off set-up. This will lead to high-gain, disruptive outcomes in the form of unprecedented mechanistic understanding for detecting the quick spread of airbone viral particles with great socioeconomic benefits visible at three levels: (1) fuelling industrial innovation and economic growth in a game-changing sector (preventive medicine); (2) reducing healthcare costs worldwide, thus enabling more resilient and efficient health systems; (3) improving human welfare.

Consortium · 1 organisation

coordinator

AGENCIA ESTATAL CONSEJO SUPERIOR DE INVESTIGACIONES CIENTIFICAS

ES · €150,000

Research fields

View the official record on CORDIS →

← Find collaborators and more funded projects

Source: CORDIS, Publications Office of the European Union. Global Research Partnerships surfaces open EU research data to help you find collaborators; we are not affiliated with the European Union.